Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,905 | -11,158 | -4,321 | -11,618 | -1,741 |
| Depreciation Amortization | 2,704 | 1,818 | 926 | 3,692 | 2,772 |
| Accounts receivable | -798 | -406 | -42 | 243 | -2,099 |
| Accounts payable and accrued liabilities | N/A | -3,048 | N/A | N/A | 369 |
| Other Working Capital | -15,168 | -10,827 | -7,540 | 705 | -8,514 |
| Other Operating Activity | 4,256 | 5,926 | 1,391 | 7,613 | 8,027 |
| Operating Cash Flow | $-25,911 | $-17,695 | $-9,586 | $635 | $-1,186 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -42 | N/A | N/A | -80 | N/A |
| PPE Investments | -1,668 | -1,341 | -642 | -2,068 | -1,817 |
| Other Investing Activity | -121 | -71 | -47 | -138 | -93 |
| Investing Cash Flow | $-1,831 | $-1,412 | $-689 | $-2,286 | $-1,910 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 66,930 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 30 | 30 | N/A | 26,558 | 26,424 |
| Financing Cash Flow | $66,960 | $30 | $N/A | $26,558 | $26,424 |
| Exchange Rate Effect | 144 | 168 | 110 | 127 | -113 |
| Beginning Cash Position | 52,035 | 52,035 | 52,035 | 27,001 | 27,001 |
| End Cash Position | 91,397 | 33,126 | 41,870 | 52,035 | 50,216 |
| Net Cash Flow | $39,362 | $-18,909 | $-10,165 | $25,034 | $23,215 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,911 | -17,695 | -9,586 | 635 | -1,186 |
| Capital Expenditure | -1,668 | -1,341 | -642 | -2,068 | -1,817 |
| Free Cash Flow | -27,579 | -19,036 | -10,228 | -1,433 | -3,003 |